Comparison of ezetimibe plus simvastatin versus simvastatin monotherapy on atherosclerosis progression in familial hypercholesterolemia

This publication has 27 references indexed in Scilit:

• European guidelines on cardiovascular disease prevention in clinical practice Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts)
  European Journal of Preventive Cardiology, 2003
• Dyslipidaemia
  The Lancet, 2003
• Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis
  BMJ, 2003
• Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia
  Journal of the American College of Cardiology, 2002
• Pharmacology of ezetimibe
  European Heart Journal Supplements, 2002
• Combination therapy: its rationale and the role of ezetimibe
  European Heart Journal Supplements, 2002
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
  Published by Elsevier ,2002
• Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
  JAMA, 2001
• Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolemia (ASAP): a prospective, randomised, double-blind trial
  The Lancet, 2001
• Effect of Statins on Risk of Coronary Disease
  JAMA, 1999